Heparin-bonded, Expanded Polytetrafluoroethylene-lined Stent Graft in the Treatment of Femoropopliteal Artery Disease: 1-Year Results of the VIPER (Viabahn Endoprosthesis with Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery Obstructive Disease) Trial
Richard R. Saxon(AmeriCorps), Michael J. Rush(Holy Cross Hospital), Richard J. Begg(Valley Health System), Paul A. Jones(Mercy Hospital and Medical Center), Tanvir Bajwa(Aurora Health Care), Charles M. Eichler(University of California, San Francisco), Dennis Gable(Baylor University Medical Center), Peter Soukas(Northwestern University), Arun Chervu(University Surgical Associates), John G. Adams(Boone Hospital Center), Gary M. Ansel(Clinical Insights), Darren B. Schneider(NewYork–Presbyterian Hospital)
Cited by 171
Related Papers
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients
|New England Journal of Medicine|2019|3.6k
Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk Patients
|New England Journal of Medicine|2004|2.9k
A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism
|JACC: Cardiovascular Interventions|2015|929
Long-Term Results of Carotid Stenting versus Endarterectomy in High-Risk Patients
|New England Journal of Medicine|2008|832
Acute and 12-Month Results With Catheter-Based Mitral Valve Leaflet Repair
|Journal of the American College of Cardiology|2012|567